22q11 microdeletion syndrome mutation detection kit
Through AccuCopy technology and multiple PCR primers combined with capillary electrophoresis, the 22q11 microdeletion syndrome detection kit has been developed to solve the problem of detection difficulties in the existing technology, and to achieve rapid and accurate detection, support early diagnosis and intervention, and improve the quality of life of children.
Patent Information
- Application Number
- CN202510226195.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-02-27
- Publication Date
- 2025-07-04
AI Technical Summary
The existing detection methods cannot effectively and economically detect 22q11 microdeletion syndrome, resulting in difficulty in early diagnosis and intervention, affecting the quality of life of children and the accuracy of genetic counseling.
AccuCopy technology was used to develop a 22q11 microdeletion syndrome mutation detection kit, which contains multiple PCR primers and internal control DNA fragments for the 22q11 region, combined with capillary electrophoresis technology to achieve fast and accurate copy number variation detection.
A rapid and accurate detection of 22q11 microdeletion syndrome mutations has been achieved, supporting early diagnosis and intervention, improving the quality of life of children, reducing birth defects, and in line with the policy of eugenics and good parenting.